| Today's Open | $0.63 |
|---|---|
| Previous Close | $0.62 |
| Daily Range | $0.60 - $0.63 |
| 52-Week Range | $0.43 - $1.62 |
| Market Cap | $76.4M |
| P/E Ratio | -2.00 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 710,370 |
| Average Daily Volume | 705,943 |
| Current FY EPS | -$0.26 |
Sector
Healthcare
Industry
Drugs
Zalicus Inc. (ZLCS) Description
A biopharmaceutical company pioneering the new field of synergistic combination pharmaceuticals, with a portfolio of product candidates in phase 2 clinical development. Website: http://www.zalicus.com/
News & Commentary
Zalicus Presents Data on Novel, Oral, N- and T-Type Calcium Channel Blockers for the Treatment of Pa
3 Promising Treatments for a Surprisingly Common Health Problem
Sneezing, coughing, sniffling? You're not alone. 40 million Americans suffer from allergies, but relief could be on the way.ZLCS's Top Competitors
(-3.23%)
(0.63%)
(2.44%)
(-0.50%)